View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Neuroendocrinology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 28, 2023
2 min read
Save

Cardiometabolic comorbidities more likely for adults with acromegaly than without

Cardiometabolic comorbidities more likely for adults with acromegaly than without

Cardiometabolic comorbidities, such as hypertension, cardiac arrythmias and diabetes, are more common in adults with acromegaly than those without the condition, according to a systematic review and meta-analysis published in Pituitary.

SPONSORED CONTENT
August 10, 2023
1 min read
Save

FDA approves once-weekly human growth hormone for children with GH deficiency

FDA approves once-weekly human growth hormone for children with GH deficiency

The FDA in June approved a once-weekly human growth hormone analog for children aged 3 years and older with growth hormone deficiency, according to a company press release.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
July 27, 2023
2 min read
Save

Most adults with acromegaly achieve normal IGF-I levels with long-acting pasireotide

Most adults with acromegaly achieve normal IGF-I levels with long-acting pasireotide

More than half of adults with acromegaly receiving the somatostatin receptor ligand pasireotide achieved normal insulin-like growth factor I levels, according to data from a long-term real-world study.

SPONSORED CONTENT
July 27, 2023
3 min read
Save

Genetic aspects of pituitary tumors: A conversation with Márta Korbonits, MD, PhD, DSc

Genetic aspects of pituitary tumors: A conversation with Márta Korbonits, MD, PhD, DSc

Márta Korbonits, MD, PhD, DSc, FRCP, uncovered a passion for endocrinology from a series of inspirational lectures during her medical training.

SPONSORED CONTENT
June 21, 2023
3 min watch
Save

VIDEO: Pituitary research presented at ENDO 2023

VIDEO: Pituitary research presented at ENDO 2023

CHICAGO —In this video exclusive, John Carmichael, MD, discusses some of the pituitary research presented at ENDO 2023, including treatments for Cushing’s syndrome and adipose effects following acromegaly cure.

SPONSORED CONTENT
June 20, 2023
7 min watch
Save

VIDEO: Chronic hormonal effects to look for following traumatic brain injury

VIDEO: Chronic hormonal effects to look for following traumatic brain injury

CHICAGO—In this video exclusive, Tamara Wexler, MD, PhD, discusses evaluation and treatment of pituitary hormone deficiencies that can occur after acquired brain injury, from mild to severe concussions.

SPONSORED CONTENT
June 15, 2023
6 min read
Save

A coming ‘renaissance in endocrinology’: A conversation with R. Scott Struthers, PhD

A coming ‘renaissance in endocrinology’: A conversation with R. Scott Struthers, PhD

R. Scott Struthers, PhD, had a lab job synthesizing peptide hormones as a college freshman. That experience launched a career featuring discovery of novel agents for endocrine diseases, women’s health conditions and cancers.

SPONSORED CONTENT
June 02, 2023
8 min watch
Save

VIDEO: Pituitary and adrenal research highlights from ECE 23

VIDEO: Pituitary and adrenal research highlights from ECE 23

In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary and adrenal research highlights presented at ECE 2023, the annual meeting of the European Society of Endocrinology, which took place in Istanbul, Turkey, in May.

SPONSORED CONTENT
May 15, 2023
5 min read
Save

Addressing glucocorticoid withdrawal syndrome in treatment of Cushing’s syndrome

Addressing glucocorticoid withdrawal syndrome in treatment of Cushing’s syndrome

To achieve optimal outcomes in Cushing’s syndrome, both clinicians and patients need to be prepared for the type and duration of symptoms that patients may experience during treatment and recovery.

SPONSORED CONTENT
February 28, 2023
2 min read
Save

Most pituitary microadenomas do not change in size over 5 years of follow-up

Most pituitary microadenomas do not change in size over 5 years of follow-up

Most adults with incident pituitary microadenomas have no change in size or a decrease in size during a median follow-up of nearly 5 years, according to findings published in Annals of Internal Medicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails